Golden State Equity Partners Checkpoint Therapeutics, Inc. Transaction History

Golden State Equity Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 01, 2023	SELL	$2.25 - $7.73 $30,037 - $103,195	-13,350 Closed	0 $0
Q1 2022 May 18, 2022	BUY	$1.53 - $3.25 $20,425 - $43,387	13,350 New	13,350 $24,000
Q1 2022 May 16, 2022	SELL	$1.53 - $3.25 $20,043 - $42,575	-13,100 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.68 - $4.46 $35,108 - $58,426	13,100 New	13,100 $41,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $299M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

Stay updated on Golden State Equity Partners with notifications on news.